Innovative noninvasive cancer surgery: Is it an MRI machine, operating desk, or ultrasound table? Actually, it’s all three. Israel’s InSightec is gaining notoriety for its newest invention, a noninvasive procedure for removing uterine fibroids and bone cancer tumors without sharp implements…or scarring. Their latest invention, the ExAblate O.R. uses ultrasound technology in an MRI environment, and is drastically changing operating rooms all over the US and the European nations.

No scalpel, no problem

This may be the gentlest, yet most effective for treating cancer we’ve seen yet. The ExAblate O.R., an Israeli invention, uses high-intensity ultrasound technology to destroy tumors and fibroid cysts buried deep within your body, all without the need for sharp scalpels. How does it work? The patient, while wide awake, slides onto an MRI table set up with various ergonomic “cradles,” robotic elements containing focused ultrasound transducers, providing greater control in eliminating harmful tumors and fibroids. And because the patient is alert during the surgery, physicians are able to monitor results in real time and make any changes necessary immediately.

Who does this benefit?

According to the website, the advantages of using MR-guided focused ultrasound surgery are substantial for both patient and surgeon.
  • Cancer surgery is noninvasive, leaving no scars.
  • Surgery is conducted on an out-patient basis, without the need for anesthesia.
  • Noninvasive cancer technique may eliminate the need for ionizing radiation treatments.
  • Ultrasound surgery is safe, and has no effect on fertility.
  • Recovery is much quicker than with traditional cancer surgeries.
  • Three-dimensional imaging provides better control, more accuracy in separating tissues and locating tumors.
  • MRI technology provides thermal monitoring, allowing doctors to gauge treated and non-treated tissue in a more controlled environment.

Who’s using this?

The ExAblate O.R. and its sister invention, the ExAblate Neuro have already won multiple awards and kudos for InSightec, including the Wall Street Journal’s Technology Innovation Award and the CE Mark in Europe for treatment of neurological disorders. The FDA has already approved its use for relieving pain associated with bone tumors. The ExAblate O.R. is already being used all over Europe, Asia, and the US for uterine fibroids, adenomyosis, and bone cancer, as an alternative to invasive surgeries. In the works, a clinical trial of the ExAblate O.R. will compare it to traditional radiation therapy in treating early-onset metastasized bone cancer. Your turn! Do you have any questions or suggestions?  Please leave your comments below. Share with your friends! If you found this article helpful, then please share with your friends, family, and coworkers by email, Twitter, or Facebook. Like this? Read more:

MRI Joint Project Saves Time & Money!

When Purchasing Medical Imaging Equipment, Go Turnkey!

GE Brings Good To MRI Technology – Silence

Source: Israel isTransforming the Operating Room – No More Scalpels or Scars Image credit